Comprehensive Guide to Hepatitis Advances

Home

/

Specialità

/

Gastroenterologia ed Epatologia

/

Comprehensive Guide to Hepatitis Advances

Editore

Elsevier

Anno

2023

Pagine

676

ISBN

9780323983686

I prezzi indicati possono subire variazioni poiché soggetti all'oscillazione dei cambi delle valute e/o agli aggiornamenti effettuati dagli Editori.

Dettagli Indice Recensioni (0)

The Comprehensive Guide to Hepatitis Advances provides the most up-to-date information on all types of hepatitis in one resource. Coverage spans hepatitis in all forms (viral, alcoholic, metabolic, drug, autoimmune, etc.), showing the implications of current research in clinical practice and discussing future research directions. Discussions focus on the scientific advancements in understanding the disease process and in the treatment of different groups of hepatitis.

This reference is perfect for basic science researchers in the field of hepatology; practicing gastroenterologists and hepatologists as well as primary care physicians attending to liver disease; and medical residents undergoing specialist training in gastroenterology and hepatology.

Features:

Provides comprehensive coverage of the different types of hepatitis
Highlights the most recent research findings related to different types of hepatitis and their impact on clinical care
Discusses future development specific to different types of hepatitis

?Section 1:?HEPATITIS: ADVANCES IN CLINICAL EVALUATION
1. Noninvasive assessment of liver disease severity: image-related
2. Noninvasive assessments of liver disease severity based on biomarkers
3. Conventional liver imaging in hepatitis
4. Nutrition in liver disease

Section II: VIRAL HEPATITIS
5. Antivirals against hepatitis viruses: basic mechanisms
6. Hepatitis A and hepatitis E
7. Hepatitis B: epidemiology, natural history, and diagnosis
8. Hepatitis B: treatment
9. Hepatitis C: epidemiology, natural history, and diagnosis
10. Hepatitis C: treatment
11. Hepatitis D

Section III: HEPATITIS: METABOLIC, ALCOHOL, AND DRUG INDUCED
12. Metabolic-associated fatty liver disease: epidemiology, natural history and diagnosis, current paradigm and definitions for MAFLD
13. Metabolic-associated fatty liver disease: pharmacological management
14. Non-pharmacological treatment approach in patients with metabolic dysfunctionassociated liver disease
15. Alcoholic hepatitis
16. Drug-induced liver injury caused by conventional drugs, using cases based on the Roussel Uclaf causality assessment method
17. Introduction to drug-induced liver injury

Section IV: HEPATITIS: CHOLESTATIC, GENETIC, AND AUTOIMMUNE CAUSES
18. Current paradigm and treatment options for autoimmune hepatitis
19. Hereditary hemochromatosis
20. Wilson disease
21. Alpha-1 antitrypsin deficiency

Section V: HEPATITIS: INFECTIONS AND SYSTEMIC CAUSES
22. Hepatitis: infections and systemic causes
23. HIV: hepatic manifestations of HIV and antiretroviral therapy
24. Systemic non-infectious hepatitis
25. Concurrent HCV or fatty liver in patients with chronic hepatitis B virus infection

Section VI: CHILDHOOD AND PREGNANCY
26. Hepatitis during childhood
27. Hepatitis during pregnancy

Non ci sono recensioni

Dettaglio

Aggiungi la tua recensione